Danielle Wallace, Assistant Professor at University of Rochester Medicine, shared on LinkedIn:
“Enjoying the Hawaiian sunrise at Pan Pacific Lymphoma Conference – here sharing our IIT-in progress, ‘ctDNA Guided Mosunetuzumab Consolidation in Older Adults with DLBCL’ aka the GOLD study.
Appreciate the support from Genentech, clonoSEQ, Lymphoma Research Foundation, Wilmot Cancer Institute and the 30 patients who have enrolled in 10 months – the highest accruing trial at Wilmot this year!”
Other articles featuring Danielle Wallace on OncoDaily.